BAA FY26C1CP53: advancing integration of in vitro topical product characterization and skin permeation data
Active Definitive Contract Awarded Last action
- Contract number
- 75F40126C00071
- Awardee
-
Certara UK LIMITED UEI WWBMG5E7KT69
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $352,968
Award facts
- Opportunity
-
- FY26 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science Special Notice · FDABAA2600123 · Posted Nov 21, 2025
- Contract value 33% obligated
-
- $352,968.00 Current, with exercised options
- $1,083,957.00 Potential, with all options
- Completion date 2% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Basic Research
- Pricing
- Firm Fixed Price
- Place of performance
- Great Britain, United Kingdom
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration awarded a $1,083,957 definitive contract to Certara UK LIMITED on September 30, 2026, for advancing integration of in vitro topical product characterization and skin permeation data.
The award stems from the FY26 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science, posted November 21, 2025, with due date of February 24, 2026. The BAA seeks basic and applied research and development proposals to support regulatory science innovation across FDA-regulated domains, with a focus on modernizing development and evaluation of FDA-regulated products. The solicitation operates under FAR 6.102(d)(2) and 35.016 and was classified under NAICS 541714 (Research and Development in Biotechnology) and PSC code AJ11 (General Science and Technology R&D Services).
Place of performance is Great Britain, United Kingdom. The contract is firm fixed price with an ultimate completion date of September 29, 2029. No set-aside was used.
Quick answers
Who was awarded contract 75F40126C00071?
75F40126C00071 was awarded to Certara UK LIMITED by Food and Drug Administration (Department of Health and Human Services) on September 30, 2026.
How much is contract 75F40126C00071 worth?
The government has obligated $352,968 on 75F40126C00071. Its potential value, with all options, is $1,083,957.
Was contract 75F40126C00071 competed?
The extent of competition for 75F40126C00071 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award